It's all in the timing-Reference-Cited by-同舟云学术

It's all in the timing

Published:2011-12-01 Issue:23 Volume:118 Page:5983-5984
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Bendall Linda J.¹

Affiliation:

1. UNIVERSITY OF SYDNEY

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/118/23/5983/1344283/zh804911005983.pdf

Reference8 articles.

1. Optimized anti-tumor effects of anthracyclines plus vinca alkaloids using a novel, mechanism-based application schedule.;Ehrhardt;Blood,2011

2. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.;Ling;Mol Pharmacol,1996

3. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.;Lowe;Cell,1993

4. Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells.;Kawamura;Br J Cancer,1996

5. Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro.;Akutsu;Leukemia,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma;PLOS ONE;2015-10-27

2. Enhanced anti-tumour effects of Vinca alkaloids given separately from cytostatic therapies;British Journal of Pharmacology;2013-03-12

3. Tubulin-targeting agent combination therapies: dosing schedule could matter;British Journal of Pharmacology;2013-03-12